Democratic Drug Pricing Push: Starting And Ending With Insulin?

03 Mar 2022

• By Michael McCaughan

When the Democratic party regained control of the US House of Representatives in 2019, their push to enact comprehensive drug pricing legislation began with a hearing on insulin. After four years, it might be ending with insulin as the sole focus after all.

The current legislative push towards drug pricing reform in the US began in 2019, when Democrats gained control of the House of Representatives and made the issue a centerpiece of their legislative activities.

That work began, literally and figuratively, with insulin: the very first witness at the very first hearing on drug pricing...